Home Other Building Blocks phenthiazamine

phenthiazamine

CAS No.:
2010-06-2
Catalog Number:
AG002D58
Molecular Formula:
C9H8N2S
Molecular Weight:
176.2382
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
98%
In Stock USA
United States
$17
- +
5g
98%
In Stock USA
United States
$33
- +
25g
98%
In Stock USA
United States
$83
- +
100g
98%
In Stock USA
United States
$247
- +
Product Description
Catalog Number:
AG002D58
Chemical Name:
phenthiazamine
CAS Number:
2010-06-2
Molecular Formula:
C9H8N2S
Molecular Weight:
176.2382
MDL Number:
MFCD00039680
IUPAC Name:
4-phenyl-1,3-thiazol-2-amine
InChI:
InChI=1S/C9H8N2S/c10-9-11-8(6-12-9)7-4-2-1-3-5-7/h1-6H,(H2,10,11)
InChI Key:
PYSJLPAOBIGQPK-UHFFFAOYSA-N
SMILES:
Nc1scc(n1)c1ccccc1
EC Number:
217-926-8
UNII:
WF2822RIUS
NSC Number:
2528
Properties
Complexity:
146  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
176.041g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
176.237g/mol
Monoisotopic Mass:
176.041g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
67.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  
Literature
Title Journal
Novel multipotent phenylthiazole-tacrine hybrids for the inhibition of cholinesterase activity, β-amyloid aggregation and Ca²⁺ overload. Bioorganic & medicinal chemistry 20121101
A novel series of l-2-benzyloxycarbonylamino-8-(2-pyridyl)-disulfidyloctanoic acid derivatives as histone deacetylase inhibitors: design, synthesis and molecular modeling study. European journal of medicinal chemistry 20120601
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. Bioorganic & medicinal chemistry letters 20101101
Synthesis, physico-chemical investigations of Co(II), Ni(II) and Cu(II) complexes and their in vitro microbial, cytotoxic, DNA cleavage studies. Journal of enzyme inhibition and medicinal chemistry 20100601
Rational design of indoleamine 2,3-dioxygenase inhibitors. Journal of medicinal chemistry 20100211
A library of novel allosteric inhibitors against fructose 1,6-bisphosphatase. Bioorganic & medicinal chemistry 20090601
4-Hex-yloxy-3-methoxy-benzaldehyde. Acta crystallographica. Section E, Structure reports online 20090601
Synthesis and Antibacterial Assessment of N-[4-(4-substituted phenyl)-1,3-thiazol-2-yl]-1,3,5-triazin-2-amine. Indian journal of pharmaceutical sciences 20090101
5-Methyl-2-[3-(4-phenylthiazol-2-yl)triazenyl]benzenesulfonic acid as a chromogenic reagent of N-cetylpyridinium chloride Synthesis, mechanism and analytical application. Talanta 20080115
Synthesis of a novel bistriazene reagent 4,4'-bis[3-(4-phenylthiazol-2-yl)triazenyl]biphenyl and its highly sensitive color reaction with mercury(II). Talanta 20070430
Microsphere-based protease assays and screening application for lethal factor and factor Xa. Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Synthesis, anti-inflammatory and analgesic activities evaluation of some mono, bi and tricyclic pyrimidine derivatives. Bioorganic & medicinal chemistry 20051115
Complexes of ruthenium(III) with some 2-aminothiazole derivatives/synthesis, properties and pharmacological studies. Arzneimittel-Forschung 20040101
Properties